Skip to main content
. 2019 Mar 4;9:42. doi: 10.3389/fcimb.2019.00042

Table 3.

Intracellular bacterial pathogens: Interactions of bacterial factors and host cell targets expected to cause metabolic reprogramming of the IBP-infected cells.

Intracellular bacterial pathogen (IBP) Interacting bacterial component Host cell target Used host cells and references
VACUOLAR IBPs
Salmonella typhimurium SopB PI3K/Akt/mTOR (+) HeLa cells
(Cooper et al., 2011)
SopB Class II PI3-kinases activate Akt HeLa and mouse embryonic fibroblast cells (MEFs)
(Roppenser et al., 2013)
SP-2 effector(s) FAK/Akt/mTOR (+) Peritoneal MPs (PEMs)
(Owen et al., 2014)
Salmochelin HIF-1 (+) HeLa cells, HMEC
(Hartmann et al., 2008)
Unknown p53 (+) HCT116, IEC-18 cells, and MEFs
(Wu et al., 2010)
Legionella pneumophila Dot/Icm effector protein(s) PI3K/Akt/mTOR (+) Mouse BMMs
(Abshire et al., 2016)
Lgt effector family mTORC1 (+) (Escoll and Buchrieser, 2018)
SidE effector family mTORC1 (–) (De Leon et al., 2017)
Mycobacterium tuberculosis Unknown PI3K/Akt/mTOR (+) PBMCs
(Lachmandas et al., 2016)
Unknown HIF-1 (+) C57BL/6 mice
(Shi et al., 2015)
Unknown p53 (+) Blood human MOs
(Galietti et al., 2001)
Brucella abortus Unknown Warburg shift THP-1 cells
(Czyz et al., 2017)
Chlamydia trachomatis Unknown PDPK1, Myc, HK-2 (+) HeLa cells, fallopian tube primary epithelial organoids
(Al-Zeer et al., 2017)
Unknown HIF-1 (+) HeLa cells
(Sharma et al., 2011)
Unknown p53 (–) HUVEC cells
(Siegl et al., 2014)
Coxiella burnetii Unknown Akt (+) Primary human alveolar MPs
(Hussain and Voth, 2012)
CYTOSOLIC IBPs
Shigella flexneri OspB mTOR (+) HeLa, mouse embryonic fibroblasts (MEFs)
(Lu et al., 2015)
Unknown Akt (+) HeLa cells
mTOR (–) (Tattoli et al., 2012)
Listeria monocytogenes InlB PI3K/Akt (+) LS174T and Jar cell lines
(Gessain et al., 2015)
InlB Met-dependent phosphorylation of mTOR (+) HeLa cells
(Bhalla et al., 2017)
Francisella tularensis Unknown PI3K (+), mTOR (+) Peritoneal MPs from C57BL/6 mice
(Edwards et al., 2013)
Capsule HIF-1 (–) BMDM of C57BL/6 mice
(Wyatt et al., 2016)

The host cells used in the studies are also indicated.

HHS Vulnerability Disclosure